End-of-life experiences” is the theme of the 2026 edition of the “Behind and Beyond the Brain” Symposium, promoted by the ...

The third edition of the BIAL Foundation's international award, the BIAL Award in Biomedicine, is now underway, with nominations open until 30 June. With the amount of 300.000 Euros, this award aims ...

PORTO, Portugal & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIAL, a pharmaceutical company based in Portugal with locations across Europe and dedicated to R&D in CNS diseases, announced today that it has ...

The third edition of the BIAL Foundation's international award, the BIAL Award in Biomedicine, is now underway, with nominations open until 30 June. With the amount of 300 thousand Euros, this award ...

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a significant milestone in its ongoing Phase 2 clinical study, ACTIVATE (clinicaltrials ...